By December 31, Lu Daopei Hospitalcompleted a total of 1081 cases of hematopoietic stem cell transplantation inChina in 2019 and has treated approximately 800 patients by using CAR-Ttechnology in clinical treatment.
4 Oral reports and 6 posters in the 61st ASH
As the corresponding author and first
author of the research report, President Peggy Lu and Director Zhang
Xian made oral reports on behalf of the medical team. Two oral reports
(abstract numbers: 224, 284) were listed in "ASH Highlights" and
attracted much attention
The cooperation platform of the Institute
of Biophysics of the Chinese Academy of Sciences, Beijing Win-win Biotech limited
company and Lu Daopei Hospital was officially launched.
Beijing Lu Daopei Hospital successfully
passed the GCP certification.
On October 31, 2019, the National Medical
products Administration (NMPA) published on official website No. 86 of 2019,
identifying 154 medical institutions such as Beijing Lu Daopei Hospital as
qualified for clinical trials of medicine, and issued "Drug Clinical
Trials Certificate of Institutional Qualification.
Academician Lu Daopei was awarded the
"Celebrating the 70th Anniversary of the Founding of the People's Republic
of China" Commemorative Medal
The 7th Lu Daopei Hematology Summit Forum
was successfully held and V Love Charity Dinner was grandly opened
The 7th Lu Daopei
Hematology Summit Forum, co-sponsored by Lu Daopei Medical Group ™ and Tsinghua
University Medical College, was grandly opened at the Beijing International
Convention Center on July 19, 2019. More than 1,200 well-known hematologists
and colleagues from China, Europe, America, Asia Pacific and other regions
attended the summit.
International Regenerative Medicine
Foundation awarded Lu Daopei Medical Group the "Stem Cell and Regenerative
Medicine Action Award"
Lu Daopei Medical Group from China won the
only international achievement award.
Lu Daopei Medical Group Synarc Lab Zero Rectification
Passed CAP Certification
First successful AML patient with CD 123
CAR-T bridge BMT
December 27, 2018 (+29 days), Mr. Wu, who suffered from acute myeloid leukemia
(AML),infusion CD123-CAR-T cells at Lu
Daopei Hospital and was successfully completed remission. Then the patient has
been successfully bridged bone marrow transplantation
and discharged with complete remission.
Hebei Yanda Lu Daopei Hospital Receives the
highest honor"AAA Credit Evaluation" and "Five-Star
Lu Daopei Hospital achieved best results in the "dual evaluation"
activity carried out by the Chinese Association of Non-Public Medical
Institutions, and awarded the highest honor"AAA Credit Evaluation"
and "Five-Star Hospital" at the annual meeting of the Chinese
Association of Non-Public Medical Institutions on January 6, 2019 .